INFECTIOUS DISEASE
An EMR Built for the Viral Load, the Resistance Profile, and the OPAT Clock
Your HIV follow-up walks in at 9:30 with three months of resistance results to review, the OPAT patient on the home-infusion service needs a weekly safety lab signed off before the visiting nurse can dose, and the new hepatitis C referral wants to know how fast you can get them to SVR12. GlaceEMR trends the viral load, holds the resistance panel as structured data, tracks the OPAT course dose by dose, and runs the ART interaction check at the moment you prescribe. GlaceRCM bills the consult, the infusion administration, and the J-code without leaving consultation revenue on the table, at a percentage of collections, with 95%+ first-pass claim adjudication and 99%+ collection rate of payer-allowed amounts*.
*Of payer-allowed amounts.
WHAT WE HEAR FROM ID PHYSICIANS
The Problems Infectious Disease Practices Tell Us About
Infectious disease is a specialty of precise longitudinal monitoring, complex regimens, and consults that have to close a loop other services cannot close themselves. The EHR most ID physicians run was built for a primary-care complaint visit. It buckles the moment you carry a real HIV panel, an active OPAT census, and a hepatitis treatment cohort all at once, and that is the load you carry every day. The list below is what we hear in the first thirty minutes of every discovery call.
Your viral load and CD4 history lives in the lab tab, not in a trend. The HIV patient you have followed for nine years has thirty-eight viral loads and thirty-eight CD4 counts in the chart, and the only way to read the trajectory is to open the lab tab and scroll. The blip you need to talk about today is invisible until you click into the right report and squint. The resistance panel from the failed regimen four years ago is buried in a scanned document the front office filed under “labs,” not parsed into structured fields you can act on. Your assessment relies on memory because the chart refuses to surface the line.
Your OPAT course is managed in a spreadsheet your nurse keeps on her desktop. The patient with vertebral osteomyelitis is six weeks into a planned eight-week course of IV ceftriaxone, the home-infusion vendor needs the weekly CBC and creatinine signed before they will dose Monday, and the line site has to be checked at the four-week mark. None of that lives in the chart as a real workflow. It lives in a side-document your nurse maintains because the EHR has no concept of an outpatient parenteral antimicrobial therapy course. When she is out for two days, the course drifts, the labs get late, and the home-infusion service calls your front desk three times in a morning.
Your consultation revenue is under-captured. ID is a cognitive, consult-heavy specialty. The complexity of a multidrug-resistant gram-negative bacteremia consult or an HIV-with-cryptococcal-meningitis transfer routinely qualifies for a 99244 or 99245, and that is the level you actually work. The note you sign at 7 PM after a thirty-five-minute conversation about regimen sequencing and a fifteen-minute resistance interpretation falls out at a 99243 because nobody on the chart side connected the documentation to the level. Across an ID panel, five to eight percent of consult revenue evaporates this way every year, all of it recoverable with the right scrubber and the right coding prompts.
Your J-codes and infusion administration codes leak. The 96365 for the IV antibiotic infusion in your office, the 96413 for the chemotherapeutic-style biologic, the J0696 for the ceftriaxone you administered, and the J2543 for the piperacillin-tazobactam are revenue lines that an internal-medicine-tuned biller routinely misses. The administration code falls off the claim, the J-code lands without the proper units, or the diagnostic linkage fails the medical-necessity edit. The infusion suite earns real money, and your current setup is asking you to bill it like a primary-care office charging for a flu shot.
Your ART and DAA prior authorizations eat afternoons. The integrase-inhibitor regimen you want to start, the boosted protease inhibitor for the resistant patient, the eight-week glecaprevir-pibrentasvir course for the new hepatitis C referral, every one of them requires a payer auth that takes forty-five minutes of nursing time to assemble manually. Your MA chases the lab confirmation, the prescribing rationale, the genotype, the fibrosis stage, and the prior-failure history out of three different parts of the chart and pastes them into a payer portal that loses the session twice before it accepts the submission. The patient waits an extra week for medication their disease cannot afford to wait for.
Your sensitive-record handling is a manual workaround. HIV records, STI panels, and 42 CFR Part 2 substance-use documentation carry heightened consent and disclosure rules. Most platforms force you to enforce those rules by hand: a separate folder, a separate set of permissions you remember to set, a release form your nurse pulls out of a binder for every outside record request. One missed permission, one wrong fax, one absent consent, and the practice has a breach to report. The compliance burden lives entirely in your staff’s heads, and the audit trail is whatever the EHR happened to log.
Your panel surveillance is gut feel. The HIV patients due for quarterly viral-load monitoring, the OPAT patients due for safety labs, the PrEP patients due for the quarterly screen, the latent-TB patients on isoniazid due for LFTs at week eight, the post-transplant patients on CMV monitoring, all of them slip past a calendar somebody is keeping by hand. Retention is clinical success in HIV care. A patient who falls out of monitoring for nine months is not a scheduling problem. It is an unsuppressed viral load and a transmission risk you did not get to talk about. Without a population-level recall workflow, your panel quietly thins on the metrics that matter most.
GLACEEMR FOR INFECTIOUS DISEASE
An EHR Designed Around the Monitoring Engine and the OPAT Tracker
GlaceEMR is ONC-certified, deployed in private practices since 1999, and backed by 30+ years of company history. Every feature below is in the platform today, not a roadmap promise. The infectious-disease configuration is wired in before training starts, so the chart your team opens on day one already knows ART regimens, OPAT courses, viral-load trending, resistance panels, and the sensitive-record handling HIV and STI data require.
Viral load and CD4 trending as a first-class chart object
Viral loads and CD4 counts trend over time as structured data on the same chart canvas as the active problem list, with the monitoring cadence each regimen requires baked in. The blip from two years ago, the suppression that held for nine quarters, and the rebound at month thirty-six all live in one visual trend the assessment can actually reference. The chart opens to the trajectory, not to a lab tab you have to click through.
Native OPAT tracker, dose by dose
Outpatient parenteral antimicrobial therapy is a workflow, not a side spreadsheet. GlaceEMR tracks the drug, the line type, the anticipated completion date, the weekly safety labs, the home-infusion vendor on the case, and the planned line removal. Monitoring-due and OPAT-lab-due alerts surface in the SmartInbox so the eight-week ceftriaxone course finishes on schedule and the home-infusion service is not calling your front desk three times a morning.
Resistance panels as structured data
HIV genotype and phenotype results, hepatitis C resistance-associated substitutions, and gram-negative susceptibility panels land in the chart as discrete fields, not as a scanned PDF buried in the document tab. The resistance interpretation from four years ago that drove the last regimen change is available the moment you open the chart, and the new genotype that came back yesterday is already linked to the regimen you are about to revise.
ART interaction checking at the moment of prescribing
The critical ART interaction check fires at the point of prescribing, tuned to the integrase, NNRTI, protease, and boosting agents your panel actually carries, and it knows the post-transplant immunosuppressant interactions that matter for the HIV-positive transplant recipient. Renal-dose flags catch tenofovir-disoproxil exposure in CKD, and the drug-drug check covers the rifampin interactions that derail latent-TB therapy in patients on a boosted regimen.
Hepatitis C cure tracking to SVR12
Hepatitis C direct-acting-antiviral treatment courses track milestone by milestone: baseline genotype and fibrosis stage, week-four on-treatment HCV RNA, end-of-treatment response, and SVR12 confirmation. Cure documentation is captured as a discrete chart event, so the patient who completed eight weeks of treatment a year ago and tested undetectable at SVR12 has the cure on the record, not just buried in a lab list the next provider has to reconstruct.
60+ lab interfaces with microbiology depth
Quest, Labcorp, BioReference, and more than 50 hospital and reference labs are connected today, with the microbiology-specific result handling ID demands. Culture results, susceptibility panels, AFB smears and cultures, NAAT results, viral PCRs, and serologies flow into the chart linked to the ordering problem. The pan-resistant gram-negative on the inpatient cross-cover patient is in your inbox before the hospitalist calls.
Sensitive-record access controls
HIV records, STI panels, and 42 CFR Part 2 substance-use documentation carry heightened access controls and consent-aware release workflows. Permissions are enforced by role at the chart level, audit trails capture every view of a sensitive record, and release-of-information requests are gated through a consent check before anything crosses the boundary. Your compliance posture is in the system, not in a binder behind the front desk.
eRx with EPCS and renal-dose intelligence
Surescripts e-prescribing with EPCS for the controlled substances ID actually writes, Id.me identity proofing, and prescribing favorites for ART, antivirals, antibiotics, and antifungals with renal dosing built in. The vancomycin and aminoglycoside dosing nomograms are inside the workflow, the prior ART regimens are one click away, and PDMP integration runs inside the prescribing screen rather than in a separate browser tab.
Hospital ADT, sepsis-consult workflow
15+ hospital interfaces deliver ADT notifications, discharge summaries, and inpatient results into the chart, with the sepsis-consult and antimicrobial-stewardship workflow ID needs when the inpatient service calls. The MRSA bacteremia patient who was just admitted on your shared service is on your dashboard, the consult template is one click, and the discharge transition into outpatient OPAT is documented in the same chart the consult lived in.
Travel medicine and pre-travel consult templates
Pre-travel consults, yellow-fever administration documentation, typhoid and JE vaccine workflows, malaria-prophylaxis prescribing, and post-travel evaluation for the febrile returning traveler are all configured as native workflows. The travel-history intake arrives through the portal before the visit and populates the destination, the itinerary, and the immunization gap so the consult focuses on the clinical decision, not on data collection.
Native telehealth for monitoring visits
HD video is built into the EHR. The HIV follow-up that does not need an in-person exam, the PrEP quarterly check-in, the post-travel evaluation for the patient already cleared, and the hepatitis C end-of-treatment visit all run in the same chart as the in-person work, with the same templates and the same coding support. The Ryan White population that struggles with transportation keeps engagement instead of falling out of care.
Population registries for ID surveillance
Care Gap and Population Registry views surface the HIV patients due for quarterly viral-load monitoring, the OPAT census active right now, the PrEP patients due for follow-up screening, the latent-TB patients due for week-eight LFTs, and the post-transplant patients on CMV surveillance. Recall logic drives portal, SMS, and phone outreach so the panel keeps moving forward on the metrics that define clinical success.
MODULES INCLUDED WITH GLACEEMR
Things Other EMRs Charge Extra For. You Get Them.
When you price out another EMR, count what is included before you compare the headline number. Most of the boxes below are upsells everywhere else. They ship with GlaceEMR. No tier games, no surprise line items at renewal, no third-party vendor management for the modules a real infectious disease practice depends on.
Native iOS and Android apps
Phone and tablet apps for providers and staff. Sign notes, review labs, message patients, see the schedule, take the hospital sepsis-consult call, all from wherever you are. Native build, not a mobile-friendly browser view, so the experience holds up at the bedside, on the drive home, and at the kitchen table when the cross-cover service calls.
CCM, PCM, TCM, RPM
Chronic Care Management for the HIV and hepatitis populations, Principal Care Management for the single-condition complex case, Transitional Care Management for the post-hospital sepsis or endocarditis discharge, and Remote Patient Monitoring where it fits. The minutes accrue, the documentation lands in the right field, the eligible time rolls into the claim, and the recurring revenue stops slipping past the billing team.
Self-check-in kiosk
Check-in on an iPad, an Android tablet, or the patient’s own phone. Demographics, consents, copay, sexual-health intake, and exposure-history updates, all completed before the rooming MA gets there. Bilingual English and Spanish, with the sensitivity language sexual-health intake demands so the patient is not handing back a clipboard the lobby could read over a shoulder.
Telehealth, PACS, DICOM viewer
HD video, integrated PACS, full DICOM viewer in the chart. The chest CT on the cavitary-lung-disease patient, the MRI on the suspected vertebral osteomyelitis, the echocardiogram on the endocarditis follow-up, all readable inside the patient record alongside the radiology report. No add-on subscriptions, no separate logins, no surprise fees on the renewal.
GlaceOffice administration suite
HR, timesheets, PTO, inventory for vaccines and infusion supplies, documents, contracts, credentials, asset management, mail handling, expense tracking, and the KPI dashboard your practice manager actually checks. Free for every Glenwood client. The yellow-fever vaccine inventory and the IV antibiotic supply both live in the same system that runs HR, instead of in three separate logins your office manager has to remember.
Multi-location, multi-provider, role-based
Grow from solo to a multi-provider hospital-affiliated practice across multiple locations on one platform without renegotiating the contract or rebuilding the configuration. Role-based access controls and audit trails throughout, with the heightened access HIV and STI records require enforced at the role layer. No per-location upcharge. Add an infusion suite or a hospital outpatient site next quarter and the chart works the same way Monday morning.
GLACERCM FOR INFECTIOUS DISEASE
A Billing Service That Knows ID Consult, Infusion, and J-Code
GlaceRCM charges a percentage of collections with no base fees, no implementation charges, and no monthly minimums. The service is built for the infectious-disease consultation code mix, the infusion-administration revenue line, the J-code complexity of IV antibiotics and biologics, and the ART and DAA prior-authorization workflow the specialty depends on.
95%+
First-pass claim adjudication. Most claims pay on the first submission, with no rework, no resubmission, and no calendar lost to denial follow-up.
99%+
Collection rate of payer-allowed amounts*. The dollars the payer contractually owes you actually arrive, because we work the queue to resolution instead of writing it off at 90 days.
$0
Implementation fee, setup charge, and monthly minimum. We get paid when you get paid, so our interests and yours line up from the day the contract is signed.
*Of payer-allowed amounts.
Consultation coding caught at the level you worked
99244 and 99245 office consults, 99254 and 99255 inpatient consults, and the high-complexity E&M levels ID actually delivers are the bread and butter of our scrubber. The Undercoding Detector flags the dense regimen-management visit billed below its level, so the multidrug-resistant gram-negative consult that took forty minutes does not fall out at a level three because nobody on the chart side connected the documentation to the level.
Infusion and J-code capture
96365, 96366, 96367, 96374, 96413, and the J-code library for the IV antibiotics, antifungals, and biologics ID actually administers live inside the scrubber as a configured rule set. The administration codes, the units, the diagnostic linkages, and the medical-necessity edits all run before the claim leaves the office. The infusion suite earns the revenue the infusion suite worked for, not whatever the claim happened to clear on the first try.
ART and DAA prior authorization
The integrase regimen, the boosted protease inhibitor, the eight-week DAA course, and the antifungal step-therapy authorization are AI-assembled from the chart and human-finished by our team. The genotype, the fibrosis stage, the prior-failure history, and the prescribing rationale all populate the auth packet without your MA leaving the encounter. The forty-five-minute manual auth shrinks to a five-minute review, and the patient does not wait an extra week for medication the disease cannot afford to wait for.
Ryan White and 340B-aware billing
For practices that participate in Ryan White HIV/AIDS programs or 340B drug-pricing arrangements, the billing service understands the grant-funded payer mix, the report-back-to-grant cadence, and the third-party-payer-first sequencing the program rules require. Your panel that depends on Ryan White grants for ART access stays whole, and the reporting your program officer needs falls out of the chart instead of demanding a separate spreadsheet.
Denial management worked to resolution
We do not drop a denial after 90 days. Every claim is tracked to complete resolution: appeals, second-level reviews, payer follow-ups, peer-to-peer when the medical necessity of a complex regimen is in dispute. The write-off only happens when you sign off on it, and the report on your dashboard tells you exactly where every disputed dollar stands today.
Percentage of collections, no base fees
No setup fees, no implementation charges, no monthly minimums. We get paid when you get paid. That is the contract, in writing, on every invoice. Your interests and ours are aligned from day one, and our incentive is to collect every dollar you earned on the consult, the infusion, and the J-code, not to bill you for activity that did not produce collections.
A named billing specialist for your panel
You get a dedicated account manager who knows ID payer mix in your state, the codes you bill, your top denials, and the consult-and-infusion revenue patterns the specialty depends on. Not a ticket queue. Not an offshore call center. They pick up the phone when you call, and they know your practice by name within a month of go-live. You will recognize their voice on the other end.
Credentialing and payer enrollment included
Provider credentialing and payer enrollment are part of GlaceRCM onboarding, not a separate engagement and not a referral to a third-party credentialing company. New providers, hospital privileges, Ryan White program enrollment, and Medicare-Medicaid revalidations are handled by the same team that runs your billing. The new associate joining the practice is billing on day one instead of waiting six months for an enrollment letter.
GLACESCRIBE FOR INFECTIOUS DISEASE
Ambient Notes Tuned to ID Vocabulary, Resistance Interpretation Included
GlaceScribe listens in the room and generates a complete consult or follow-up note structured the way ID writes: infection history, exposure history, regimen and monitoring plan, resistance interpretation, antimicrobial stewardship rationale, and the OPAT plan when one is in play. It is built on HIPAA-compliant AI infrastructure from Amazon, Google, Anthropic, Deepgram, ElevenLabs, and other enterprise AI providers. Multi-vendor architecture preserves operational redundancy and continuous improvement, so the scribe gets better over time without ever depending on a single upstream vendor.
The scribe folds lab trends and the resistance interpretation directly into the assessment, so the HIV follow-up note that used to require fifteen minutes of free-text dictation now arrives with the viral-load trajectory, the CD4 trend, the active regimen, and the interaction-check status already structured. The hepatitis C end-of-treatment note carries the SVR12 result as a discrete event. The OPAT follow-up note attaches the week’s safety labs and the line status without your nurse retyping anything. ICD-10 and CPT suggestions surface alongside the draft note, including the consult-level evaluation and the infusion-administration codes that match the day. All suggestions are reviewed by you before signing.
It learns your voice, your abbreviation patterns, and your preferred phrasing over time. The first month it sounds like a careful infectious-disease fellow trying to write the way you write. By month three it sounds like you. It knows the difference between “viral load undetectable” and “below the limit of quantification,” it knows that “cure” in hepatitis C means SVR12 and not end-of-treatment response, and it understands that “completion” of an OPAT course is a chart event with a date, not a hand-wave. Nothing reaches the chart until you approve it, and the codes never touch the claim until you sign the note.
Up to four simultaneous speakers are captured cleanly, so a partner, an adult child, an interpreter, or a home-health nurse in the room is documented alongside the patient without scrambling the assessment. The scribe runs in person and in telehealth, and the same chart receives the note either way. Patient-facing language is supported in English and Spanish, so the Spanish-speaking PrEP patient gets the same encounter experience while the clinical documentation lands in English for billing and reporting.
You will feel it most in the visits where the typing was always the bottleneck. The new HIV consult who shows up with twelve years of records to unpack. The vertebral osteomyelitis OPAT initiation where you have to document the drug, the line, the duration, the monitoring plan, and the home-infusion handoff in one note. The family meeting around the elderly endocarditis patient where everybody is talking at once. The note that used to eat thirty minutes after clinic now needs three minutes of review while the MA is rooming your next patient, and the HPI captures what your patient actually said, not the abbreviated version you would have typed from memory at the end of the day.
By week six, most ID physicians tell us they are getting ninety minutes to two hours of their evening back, every weeknight. The practice’s chart-completion report says the same thing, in fewer words. The visit ends. The note finishes. The afternoon does not bleed into the night, and the consult queue you still owe at 6 PM is not waiting for the typing to catch up.
POWERED BY GLACEIQ
30+ AI Features, Tuned to the Infectious-Disease Day
Every GlaceIQ capability is a suggestion. You review and select. Codes wait for your approval before they touch a claim, and notes wait for your signature before they leave the chart. Compliance-first, physician-in-the-loop, every time. The list below is what runs in the background of your day on GlaceEMR, working on the cognitive load an ID specialty carries today by hand.
Pre-charting from regimen, viral load, and OPAT status
Before the visit, GlaceIQ assembles a pre-chart summarizing the active ART or antiviral regimen, the latest viral load and CD4, the OPAT week-and-status if one is running, the open monitoring labs, the resistance history, and the last-visit plan items still open. Your MA reviews it before you walk in, so the first thirty seconds of the encounter are spent on the patient, not on chart review.
Lab Interpreter for monitoring panels
A Lab Interpreter reads HIV viral load and CD4 results in the context of the active regimen, OPAT safety labs in the context of the antibiotic and the renal status, hepatitis C end-of-treatment and SVR12 results in the context of the DAA course, and TB-therapy LFTs in the context of the isoniazid week. The interpretation is a suggestion you review, and the trend chart is updated before you click into the result.
Antibiotic ordering decision support
When you order an antibiotic, GlaceIQ surfaces susceptibility data from the patient’s prior cultures, the local antibiogram where available, renal-dose adjustments, and stewardship-aligned alternatives where the spectrum or duration is broader than the infection warrants. The suggestion is yours to accept or override. The decision support sits beside the order, not in front of it.
Drug Cost Comparator for ART and DAA decisions
The Drug Cost Comparator factors patient-side cost, payer formulary, and 340B or Ryan White program eligibility into the ART regimen and DAA treatment decisions before the prescription leaves the office. The patient walks out with a regimen they can actually fill, not one the pharmacy benefit denies on Wednesday and your MA has to chase Thursday morning. Adherence climbs because the financial barrier was solved at the encounter.
Denial prediction before submission
GlaceBillSmart scores each claim for denial probability based on payer history and code combinations, so the billing team fixes problems before submission instead of working denials after the EOB arrives. The consult that would have failed on medical necessity gets the documentation it needed, the infusion claim that would have failed on diagnostic linkage gets the linkage fixed, and you can still adjust the note while the encounter is fresh.
Per-code performance at charge entry
During charge entry, GlaceIQ shows expected reimbursement, denial probability, and payment timeline per code by payer. You see the dollar implications of a coding decision while you can still adjust documentation. Your 99244 with the supporting MDM goes out as a 99244. Your 96365 lands with the right J-code and the right units. Your high-complexity inpatient consult does not fall out at a level three because the documentation prompt was missed.
PrEP recall and STI-screening cadence
PrEP patients due for the quarterly visit, the HIV screen, the STI panel, and the renal-function check surface as a recall queue with portal, SMS, and phone outreach already configured. The patient who started PrEP four months ago and never came back for the quarterly follow-up is in the queue, not lost. The MIPS HIV-screening measures and the STI-screening quality lines fall out of the workflow as a byproduct of good care.
Patient education in English and Spanish
GlaceIQ suggests condition-specific patient education for the visit’s diagnoses, shareable to the portal in English or Spanish after you review and approve. ART adherence material for the newly-diagnosed HIV patient, hepatitis C cure expectations for the new DAA start, OPAT home-infusion instructions for the patient going home with the PICC line, and PrEP risk-reduction material for the new initiate, all in language the patient can actually read.
AI-powered prior authorization
For ART regimens, DAA courses, antifungal step-therapy, and biologic-class orders, GlaceIQ assembles the documentation packet from the chart, including the genotype, the fibrosis stage, the resistance history, and the prescribing rationale. The billing team finishes, validates, and submits. The forty-five-minute manual prior-auth project shrinks to a five-minute review, and the patient gets the medication their disease cannot afford to wait for.
PATIENT ENGAGEMENT FOR INFECTIOUS DISEASE
Reach the Panel Where Retention Is Clinical Success
Your patient engagement stack runs on portal, mobile app, kiosk, SMS, email, and phone, with English and Spanish on every patient-facing surface, and with the sensitivity that HIV, STI, and substance-use records require. The Ryan White patient who only opens text and the post-transplant patient who only opens email both end up on the schedule, both complete intake before they walk in, and both stay engaged with monitoring at the cadence the regimen requires.
Practice-branded portal and mobile app
Labs, secure messaging, scheduling, bill pay, sensitive-record intake forms, and telemedicine, all under your practice name, your logo, and your colors, with the access controls HIV and STI data demand. Patients install one app, recognize the brand on their phone, and stay there. Adoption beats the generic vendor-branded portal every time, because the patient trusts the practice they already know.
GlacePhoneSmart 24/7 line
AI phone agent answers as your practice in English or Spanish, books into real-time scheduler slots, runs PrEP recall and viral-load monitoring reminders, fills cancellations, and surfaces voicemail summaries to your staff. The front desk stops drowning in calls. The Ryan White patient who reaches the practice at 10 PM still books the quarterly visit for next Tuesday, and the home-infusion vendor that calls about the OPAT order reaches a structured intake instead of a voicemail.
SMS and email recall on the right cadence
HIV quarterly viral-load recalls, PrEP follow-ups, OPAT safety-lab reminders, hepatitis treatment milestone nudges, post-travel return checks, and STI re-screen prompts, all in patient-preferred language and channel, on the cadence the care plan calls for. Replies route back into the chart as structured tasks, not into an inbox somebody has to read on Monday morning. The patient who would have fallen out of HIV care at month nine is back in the chair at month four.
Bilingual kiosk and sensitive-intake forms
Self-check-in on iPad, Android tablet, or the patient’s own phone, in English or Spanish. AI-powered sexual-health, PrEP, and travel/exposure intake before the visit, with the privacy posture sensitive intake demands. The rooming MA spends her time on vitals and discussion instead of typing demographics off a clipboard, and the patient does not hand back a sexual-history form the lobby could read over a shoulder.
WE KNOW YOUR CODES
We Have Billed Your Mix Before
You already know your codes. We have built the workflows, the scrubber rules, the documentation prompts, and the denial templates around them. The list below is the short version of what runs every day inside the platform for an infectious disease practice:
- 99244, 99245: high-complexity office consultation
- 99254, 99255: high-complexity inpatient consultation
- 96365, 96366, 96374: IV antibiotic infusion administration
- 96413: chemotherapeutic-style biologic infusion administration
- J0696, J2543, J1956: ceftriaxone, piperacillin-tazobactam, levofloxacin J-codes
- 99490, 99439, 99491: Chronic Care Management for HIV and hepatitis populations
- 99495, 99496: Transitional Care Management for post-hospital sepsis or endocarditis
- 87536, 87901, 87903: HIV viral load, genotype, and phenotype resistance
SWITCHING IS EASIER THAN YOU THINK
Coming From Another EMR
Most infectious disease practices we onboard are leaving a legacy EMR platform, a horizontal EMR software product, or a hospital-tethered enterprise system that never fit the outpatient ID workflow. We have migrated all of them. The transition is the part you dread most, and it is the part we have done hundreds of times.
$0 implementation fee. Data migration is included in the contract: historical patient records, problem lists, current medications, allergies, and outstanding orders, plus the viral-load and CD4 history that makes a trend meaningful, the resistance panels, the hepatitis treatment milestones, and the OPAT history. EMR go-live in under one week of focused workflow training. RCM transition over 4 to 8 weeks with payer enrollment running in parallel, so the cashflow gap is the smallest possible. We recommend a 30 to 90 day overlap with your previous vendor while the new chart proves itself.
Provider training is delivered in pieces around your real schedule, not as a multi-day disruption that forces you to cancel patients. Your account manager runs the migration and stays your account manager after go-live, so the person who answers your call in month six is the person who set up your workflows in week one. Glenwood has been physician-founded and privately held since Christmas Eve, 1994, when our founder helped his physician wife acquire a private practice in Connecticut. 30+ years in market, no outside investors, no roadmap roulette.
Support runs 7:00 AM to 8:00 PM Eastern Time on weekdays, with 24×7 on-call coverage for urgent or critical issues, so the practice that has a sepsis-consult question at 6:30 AM Pacific or 10:00 PM Eastern still reaches a person. You also get unlimited online training through onboarding, included online training for new staff who join later, and a self-help library of workflow documents and videos for the moments when somebody just needs to remember how something works. The platform sits on HIPAA-compliant infrastructure with LUKS full-disk encryption at rest, ONC certification, and PCI-DSS compliance for the patient-pay surfaces.
What changes on day 1, day 30, and day 90
Day 1. You log in to a chart that already holds your migrated patient history, your active problem lists, your current medication lists, the viral-load and CD4 trends, and the resistance results from your previous system. The infectious-disease configuration is already wired in: your consult templates, your HIV follow-up and OPAT follow-up smart phrases, your order sets for ART initiation and DAA treatment, your antibiotic favorites with renal dosing, your screening calculators. You see a chart that looks like a real ID chart, not a blank install asking you to build one. Your first few visits run slower because the workflow is new. By the end of the first day, your hands start to remember where everything lives.
Day 30. You are charting faster than you did on the old system because the templates match the way you actually document. You are using GlaceScribe on most visits and your consult HPIs no longer slow you down. Your first month of CCM time on the HIV and hepatitis populations has rolled into a claim, and your first month of submissions is already on the dashboard. You and your account manager have done the first formal walk-through of the denial queue together. The OPAT tracker is live, the recall workflows are live, and your front desk is starting to fill tomorrow’s schedule from the recall list rather than from whoever calls in.
Day 90. Your first quarter’s RCM dashboard shows the new shape: cleaner claims, faster posting, fewer denials parked in the 60-90 bucket. Consultation revenue is up because the documentation prompts are landing. Infusion and J-code capture is up because the scrubber knows the rules. ART and DAA prior auths run on a five-minute review cycle. The PrEP quarterly recall and the HIV viral-load monitoring queue have closed care gaps for patients you would not have reached otherwise. GlacePhoneSmart has visibly cut your front-desk call volume. The conversation with your account manager turns from migration triage to optimization, the parts of the platform you are ready to use harder next quarter.
QUESTIONS WE HEAR EVERY WEEK
Infectious Disease Practice FAQ
The questions below come up in almost every discovery call with an infectious disease practice. Short answers below; the longer conversation happens on the demo. Tap any question to expand the answer.
Does GlaceEMR track an OPAT course as a real workflow, not a spreadsheet?
Yes. The OPAT tracker is a native chart object. The drug, the line type, the planned duration, the weekly safety labs, the home-infusion vendor, and the anticipated line removal all live as structured fields. Monitoring-due and OPAT-lab-due alerts surface in the SmartInbox on the cadence the regimen requires. When the home-infusion vendor calls about the weekly CBC, your nurse opens the chart and the lab is already attached to the case. The eight-week course finishes when it is supposed to finish, and the discharge from OPAT is a chart event, not an email.
How does GlaceEMR handle HIV viral load and CD4 trending across years?
Viral load and CD4 are trended as structured data on the same chart canvas as the active problem list. The trajectory across the entire chart history is visible without leaving the encounter. Resistance panels are captured as discrete fields, not as scanned PDFs, so the genotype that drove the last regimen change is one click from the assessment. The ART interaction check fires at the moment of prescribing. The HIV-specific care-gap and recall workflows surface the patients due for quarterly monitoring across the panel, so retention is managed at a population level rather than chart by chart.
Is GlaceScribe HIPAA-compliant, and how does it handle resistance interpretation?
Yes, fully HIPAA-compliant. GlaceScribe runs on HIPAA-compliant AI infrastructure from Amazon, Google, Anthropic, Deepgram, ElevenLabs, and other enterprise AI providers, all under business associate agreements. The multi-vendor architecture preserves operational redundancy. The scribe folds the resistance interpretation, the viral-load trajectory, and the regimen-management plan into the assessment as structured codeable content. Up to four simultaneous speakers are supported. All coding and order suggestions surface for your review before any signing. Nothing reaches the chart until you approve it. Audio is processed in transit, the resulting note is stored in your single-tenant chart database, and the data never trains a shared model.
How does GlaceRCM bill infusion administration and J-codes?
The scrubber knows 96365, 96366, 96367, 96374, and 96413, and it knows the J-code library for the IV antibiotics, antifungals, and biologics ID administers. Administration codes, units, diagnostic linkages, and medical-necessity edits all run before the claim leaves the office. The 95%+ first-pass adjudication and 99%+ collection rate of payer-allowed amounts hold across the infusion line. Practices that participate in Ryan White or 340B arrangements get the program-aware sequencing they need, including grant-funded payer mix and the report-back-to-grant cadence.
Does Glenwood handle ART and DAA prior authorization?
Yes. GlaceIQ assembles the documentation packet from the chart, including the genotype, fibrosis stage where applicable, resistance history, and prescribing rationale, then the billing team finishes, validates, and submits the authorization. The forty-five-minute manual auth shrinks to a five-minute review. Antifungal step-therapy and biologic-class authorizations run through the same workflow. The patient gets the medication their disease cannot afford to wait for, and your MA stays in the encounter instead of in a payer portal.
How are sensitive HIV and STI records protected on the platform?
HIV records, STI panels, and 42 CFR Part 2 substance-use documentation carry heightened access controls at the role layer. Audit trails capture every view of a sensitive record. Release-of-information requests run through a consent gate before anything crosses the boundary. The platform sits on HIPAA-compliant infrastructure with LUKS full-disk encryption at rest, ONC certification, and PCI-DSS compliance on patient-pay surfaces. Sensitive intake forms route through the portal with the privacy posture sexual-health and PrEP intake demand.
How long is implementation, and what does training actually look like?
You go live on the EMR in under a week. Your RCM transition runs 4 to 8 weeks alongside payer enrollment. We handle your data migration in 2 to 4 business days, including viral-load and CD4 history, resistance panels, hepatitis treatment milestones, and OPAT history. Your providers train in pieces around real clinic, not in a multi-day block that forces you to cancel patients. The core clinical training runs 2 to 4 focused hours per provider, and you stack targeted follow-ups for advanced modules, specialty templates, telehealth, mobile, and the AI documentation tools on whatever cadence works for your schedule. Every role gets training during onboarding: front desk, MAs, nurses, providers, billers, administrators, super-users, all unlimited. We recommend keeping your previous vendor running alongside us for 30 to 90 days so you can keep operating normally while the new platform proves itself.
“[Specialty-specific testimonial quote, replace with verified Infectious Disease physician quote or remove this card.]”
[Physician Name, MD]
[State]
If you carry adjacent panels, see how GlaceEMR runs internal medicine, gastroenterology, pulmonary, and nephrology.
See What Glenwood Can Do for Your Practice
A 20-minute working call. We show you the platform on your specialty’s actual workflows, not a generic demo.